Curbing Demodex Blepharitis: Meet the Mitey Challenge (CE Webcast)

Activity Description and Purpose

Demodex are ectoparasites that inhabit human hair follicles, including those on the face and eyelashes. Large infestations can cause Demodex blepharitis, a condition that has been associated with dry eye, meibomian gland dysfunction, and rosacea. Until recently, there were no US Food and Drug Administration–approved treatments for Demodex blepharitis, and off-label treatments were not reliably effective. This webcast covers the diagnosis and treatment of Demodex, including the recently approved treatment lotilaner, 0.25%.

Target Audience

This educational activity is intended for optometrists.

Learning Objectives

After completing this activity, participants will be better able to:

  • Review best practices in the diagnosis of Demodex blepharitis
  • Develop individualized treatment plans for patients with Demodex blepharitis
Course summary
Available credit: 
  • 1.00 COPE
Course opens: 
12/06/2024
Course expires: 
12/31/2025

Faculty

Ian Benjamin Gaddie, OD, FAAO
Owner and Director
Gaddie Eye Centers
Louisville, Kentucky

Disclosure Policy

MedEdicus requires that anyone who is in a position to control the content of this educational activity disclose all relevant financial relationships with any ineligible companies. Financial relationship information is collected and resolved prior to the educational activity. All relevant relationships have been mitigated.

Faculty

Ian Benjamin Gaddie, OD, is a consultant for AbbVie Inc, Harrow, and Tarsus Pharmaceuticals, Inc; and is on the speakers bureau for AbbVie Inc, Aerie Pharmaceuticals, Inc, and Bausch & Lomb Incorporated. 

Peer Reviewer

This activity was peer reviewed. The peer reviewer has no relevant relationships with ineligible companies to disclose.

Planners, Managers, and Writers

MedEdicus planners, managers, and writers have no relevant relationships with ineligible companies to disclose.

Accreditation Statement

COPE approved for 1.0 CE credit for optometrists.
COPE Course ID: 95189-TD (Asynchronous)
COPE Course Category: Treatment/Management of Ocular Disease
Administrator:

This activity, COPE Activity Number 129732, is accredited by COPE for continuing education for optometrists.

Disclosure of Commercial Support

MedEdicus LLC has received commercial support from Tarsus Pharmaceuticals, Inc, for this activity in the form of an unrestricted educational grant.

The content of this COPE-accredited CE activity was planned and prepared independently by MedEdicus LLC without input from members of an ineligible company.

Off-Label Discussion

This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.

Sponsored by

Provider Contact Information

For questions about this educational activity, please contact MedEdicus LLC at info@mededicus.com.

Disclaimer

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the State University of New York College of Optometry, MedEdicus LLC, or Tarsus Pharmaceuticals, Inc.

This CE activity is copyrighted to MedEdicus LLC ©2024. All rights reserved. MedEdicus does not claim copyright to material included herein owned by third parties for which attribution or citation has been made. 329.1

Available Credit

  • 1.00 COPE
Please login or register to take this course.

Clicking Register/Take course indicates that you have reviewed the CE information for this activity.